BioCryst Pharmaceuticals, Inc. (BCRX) Social Stream
Biocryst Pharmaceuticals Inc (BCRX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Biocryst Pharmaceuticals Inc.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 11 | $30 | $12 | $19.363 | $16.68 | 16.09% |
| 2021-12-10 | 11 | $30 | $14 | $19.727 | $16.68 | 18.27% |
| 2021-12-13 | 11 | $30 | $14 | $19.636 | $16.68 | 17.72% |
| 2022-01-11 | 11 | $30 | $14 | $19.818 | $16.68 | 18.81% |
| 2022-01-26 | 10 | $30 | $14 | $20 | $16.68 | 19.9% |
| 2022-02-23 | 10 | $30 | $14 | $20.363 | $16.68 | 22.08% |
| 2022-02-24 | 10 | $30 | $14 | $21 | $16.68 | 25.9% |
| 2022-02-25 | 10 | $30 | $14 | $21.181 | $16.68 | 26.98% |
The Trend in the Analyst Price Target
Over the past 22 months, BCRX's average price target has gone up $12.75.
BCRX reports an average of 30.82% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-04 | 11 | 30 | 16 | 21.270 | 15.66 | 35.82% |
| 2021-09-18 | 11 | 30 | 16 | 21.270 | 15.70 | 35.48% |
| 2021-09-19 | 11 | 30 | 16 | 21.270 | 15.70 | 35.48% |
| 2021-11-04 | 11 | 30 | 12 | 19.363 | 11.61 | 66.78% |
| 2022-02-25 | 10 | 30 | 14 | 21.181 | 17.06 | 24.16% |
BCRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.2 | 9 | 0 | 1 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
Over the past 26 weeks, BCRX's average broker recommendation rating improved by 0.8.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how Biocryst Pharmaceuticals Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -854.66% of that group.
- In the context of Pharmaceutical Products stocks, Biocryst Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 105.36% of them.
- In the context of stocks in the mid market cap category, Biocryst Pharmaceuticals Inc's number of analysts covering the stock is greater than 903.88% of them.
- In the context of stocks in the mid market cap category, Biocryst Pharmaceuticals Inc's average analyst price target is higher than 229.45% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Biocryst Pharmaceuticals Inc are BCAB, ALVR, and ALLO.
Is BCRX a Buy, Hold or Sell? See the POWR Ratings now!